{"name":"Ying HUANG","slug":"ying-huang","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"concomitant therapy","genericName":"concomitant therapy","slug":"concomitant-therapy","indication":"Other","status":"marketed"}]}],"pipeline":[{"name":"concomitant therapy","genericName":"concomitant therapy","slug":"concomitant-therapy","phase":"marketed","mechanism":"Concomitant therapy refers to the simultaneous administration of two or more drugs to enhance therapeutic efficacy or manage multiple conditions.","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMitgFBVV95cUxNRXdWeEtQUjNqSFRWV3VuVFFNWU95V3BvbkRLM1k5SnViUTlrNGlOc1hCMURNZFdMME4tNU5jcTBRd3Y4TTJNNk04TUFsMC1scm50VGpkYWZfdHFUUUh2ZU95Snc3eHJWNEpTeW14OFF6UjR3Z0tUY2lVTUxJaVphakxiM0FlRTVCbmpEMU11T3RZSHA3SlhEampmb3VPX0o4c05laHplU2s1R3VDQ3k1NVRvX3Rndw?oc=5","date":"2026-03-12","type":"regulatory","source":"Fierce Pharma","summary":"Legend remains bullish on Carvykti growth despite threat from J&J’s Tecvayli - Fierce Pharma","headline":"Legend remains bullish on Carvykti growth despite threat from J&J’s Tecvayli","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiekFVX3lxTFBrNFhiOXVaT0hDdE9ET2ZLRmx3ZEZYdDhIbHNqRUh6a2V0N3RpaERPRVhlczNHU0RaZzU4YkVWTm9kODFOamlpOFNzY3BDRGZpU0F5TGpOODM2X29uR1d5dHZZUW42NEYwQ0J2WUN4UC1wX1NZaXhDLTdR?oc=5","date":"2026-01-14","type":"pipeline","source":"Fierce Pharma","summary":"JPM26, Day 3: AbbVie touts 'clear line of sight' to continued growth into 2030s - Fierce Pharma","headline":"JPM26, Day 3: AbbVie touts 'clear line of sight' to continued growth into 2030s","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizgFBVV95cUxORzRQdDI0TWJJWUdPX285TmFMQ0k0LUp6Zmh1aE1WVVR4TG5GTHhzSnJoak52TEVBWnNxS1ZLN1E1LU5UZTJnaERQUEdiM2NRNy00UkhFQlFrLVRCSzVtbDRJcjByUmhkbzdlNm1YelN4c0RManhMaGpGZVpVbGxIMmRqQnZ1X19YSnpOaVNNUlc2YzZSU2Q5X2htNGJseW9leWVGTFZKOEIyTzl5MzVKZVhnVE1oeUwxRWRSOVc4cWphVFVidFdiUW5ZakVIQQ?oc=5","date":"2025-11-29","type":"pipeline","source":"The Pharma Letter","summary":"China’s moment is now: perspectives on the inexorable rise of Chinese biopharma innovation - The Pharma Letter","headline":"China’s moment is now: perspectives on the inexorable rise of Chinese biopharma innovation","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiigFBVV95cUxNTXd3V05FUnBwMlRnUV96VWFoY3BCUDE0bVdYVGtNUEFLREg5ejdTZWMxY29BYl9lZFV2NVR1d010Y21mOTFfT1VoQjNuRUdMT3B5S1R1LVJidUZBQm1aekpHaDNVUGVDYTRoUjBxa2dJcnExM055UlU1dlZ4V3VaQkVNd08ydmpDWUE?oc=5","date":"2025-11-21","type":"pipeline","source":"PHILADELPHIA.Today","summary":"Legend Biotech Opens New Philadelphia Research & Development Center, Plans For 50-Plus Staff - PHILADELPHIA.Today","headline":"Legend Biotech Opens New Philadelphia Research & Development Center, Plans For 50-Plus Staff","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxOYm9TblVXZXlLZnFUVDUxZ1h1NlA2bXhEWUxuODZScHR2WTZTaVFtaElUNWVRd2xJdlI0ZEdISGFFaDY2bXRaakVYc3dYV2NyV1NVT1lHWkgxNnNnYnlCZTFRWmhPQXpYcjVRWUtnUDZtdXpLcEdxMFZocHNTNy1IRG1BODU5aE54NV9rUTVWOFdlT2dpQlNHanJKRWlkSzB2X3lHa0lmSUY5UQ?oc=5","date":"2025-11-12","type":"trial","source":"Endpoints News","summary":"Chinese biotechs are shedding their fast-follower reputations as innovation surges - Endpoints News","headline":"Chinese biotechs are shedding their fast-follower reputations as innovation surges","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisgFBVV95cUxQSTc5T3dmbUJaN0hSOXVGQXFsSi00Z2F4Mk54UmZjdU9JeHhsd3o1N2hFZllWTXEwT3plX0hIeVdjdE5OdDVHbEpVeS1mRDBkRWI1dkJSVnFxVUwyLXdTQVhhLTJqTUNyNFlESmlQR3QtQXNXaGdMaTJ4SEFVRDZTdW4xTERSS3RWZ2Myak5lNGlwZi14UUtHSU9Lc1ZLQTBsVzU0LUtENnBwWXBZUmU4azlR?oc=5","date":"2024-08-09","type":"pipeline","source":"Fierce Pharma","summary":"Legend Biotech CEO takes 'close look at business' amid geopolitical risk, M&A rumor - Fierce Pharma","headline":"Legend Biotech CEO takes 'close look at business' amid geopolitical risk, M&A rumor","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxOdXV3N3pILUh0b0dwc1ZVQWRNb2ZYVkZ3ejQ0Vnh6ZXcxdExhbE1TZXk2U3N1aGdxT3VadUZkeGFxLUgtcENaUUpvS2NQdWo0Z25QYlhPVWNPV3ZYM2VjdmgwVkN3Y2tjTFJKNUJhVThIaFZ5cWY2ZDRtVGFvQ2FSRE1SM0FmN3RJb2ctQzlNS0c?oc=5","date":"2024-06-14","type":"pipeline","source":"ScienceDirect.com","summary":"Journal of Pharmaceutical Analysis - ScienceDirect.com","headline":"Journal of Pharmaceutical Analysis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxPYi1ZcGRZSGFxTlBwbGJWM0RZdlZ2NjBQX0VWX1FMR3BFWHAydFlMbUVYOUdweS1DeXVWOFIwZjRMN3BwUW90ZGY1LUFicDBqd2ZzR2RkV29iOU5KTVJVcWYzWVRnTG9mMGJwT0xiZjhpdGowT1lKVk5uY2FFbGdFOXVLSGpsb3UyZFJTaXJMZkNseGQ1Y3JHV2V1TERxNFV4Y24xR1k4end2VG5JZmxGWlVLTUE0ZUZQMlE?oc=5","date":"2024-05-30","type":"pipeline","source":"Timmerman Report","summary":"Recognizing 11 Asian-American Executives Shaping the Future of Biopharmaceuticals - Timmerman Report","headline":"Recognizing 11 Asian-American Executives Shaping the Future of Biopharmaceuticals","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifkFVX3lxTFAxbk42Y2JMaDd5S2dyc2NzVHh2ME5jT20tOUZ6Q05fNG1EbGR4b2lBS29NQTN3cnRxQVdxUFJ4cnA4WEJUQmFyaWJST3dxajNDZTB0SUc1SUJ3Smd3V1ZWZHN3NVBtUjdBMzhVTll5NjRZME1TQlR1Y3R2VTZ1dw?oc=5","date":"2023-06-05","type":"deal","source":"Pharma Voice","summary":"Janssen and Legend’s longtime collaboration lands a CAR-T win at ASCO - Pharma Voice","headline":"Janssen and Legend’s longtime collaboration lands a CAR-T win at ASCO","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwAFBVV95cUxOdlp4TURIUXUzd1Q3RUVaYXpvUTVmSC1HUVVXOWx4Q0RyaFRMQ21HcFMyS0hsYlFEVXNIQmZ6SDRfQXdVMElPQ0hlTS1Ec0QxSnJyMS1Nb2xYRG5TM1YwTkl0NE82ZTZmWF9oZ0dSc3M5TDdqNlI0MGFoS1E1TXRic3c5dGMzQkpVaXJLR0NJWm0yNEhkSG1udW52WnUxN2E1Q0E1c2hKZTZpak9ndkhGUGV1QmNpMHJGZ1ZiaEFzY2w?oc=5","date":"2022-07-25","type":"pipeline","source":"WesternU News","summary":"WesternU College of Pharmacy team receives $1.6 million NIH grant for skin cancer chemoprevention - WesternU News","headline":"WesternU College of Pharmacy team receives $1.6 million NIH grant for skin cancer chemoprevention","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxPNzgzeVhtdGVCQWh2azZ3RUpZaUFKSVR2MzVBT2N2QXNTT1JsVnotcWdLVkU4RVJUV3RsOUd5X3FMaExmX2xodkFYVHlNdGNSR1d3ZzJXbkVWRlFlV3p4SEFLcWNzWVJUWVVVMVdtS3EzRUtkM1FRZlhEVkN2WGZZOWN3MVRZMjI5VTdTMHVMekowZXlhbkFrZlhYaDVZd2ppcmc?oc=5","date":"2021-05-27","type":"pipeline","source":"BioSpace","summary":"Legend Biotech’s CEO Ying Huang on Cilta-cel’s High PFS in Myeloma Patients - BioSpace","headline":"Legend Biotech’s CEO Ying Huang on Cilta-cel’s High PFS in Myeloma Patients","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwFBVV95cUxQdWh4NFFBTXhabGtfYlVqWkh4cER6TUNpdjlMMGlKQUYxdC11QjYyV01QZ0VRODJ6NGs5SHh2aHJTNl9yRnZzcHNPUlpUa0lfYjJsUGhYSzRfRDBlWTVjTzRNZGpEYkJBOFVYbkZpS2NILVl5Y2N2bHNpVjNLc3B2NjhXcVV5M2lvdzhhS2Mydw?oc=5","date":"2020-09-21","type":"pipeline","source":"citybiz","summary":"Legend Biotech Appoints Ying Huang as Interim CEO - citybiz","headline":"Legend Biotech Appoints Ying Huang as Interim CEO","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"marketed":1},"enrichmentLevel":2,"visitCount":4,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}